Ficolin-2, which was initially identified as L-ficolin, is a protein that in humans is encoded by the FCN2gene.[1][2]
The product of this gene belongs to the ficolin family of proteins. This family is characterized by the presence of a leader peptide, a short N-terminal segment, followed by a collagen-like region, and a C-terminal fibrinogen-like domain. This gene is predominantly expressed in the liver, and has been shown to have carbohydrate binding and opsonic activities. Alternatively spliced transcript variants encoding different isoforms have been identified.[2]
References
↑Endo Y, Sato Y, Matsushita M, Fujita T (Feb 1997). "Cloning and characterization of the human lectin P35 gene and its related gene". Genomics. 36 (3): 515–21. doi:10.1006/geno.1996.0497. PMID8884275.
Edgar PF (1996). "Hucolin, a new corticosteroid-binding protein from human plasma with structural similarities to ficolins, transforming growth factor-beta 1-binding proteins". FEBS Lett. 375 (1–2): 159–61. doi:10.1016/0014-5793(95)01205-S. PMID7498469.
Matsushita M, Endo Y, Taira S, et al. (1996). "A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin". J. Biol. Chem. 271 (5): 2448–54. doi:10.1074/jbc.271.5.2448. PMID8576206.
Le Y, Tan SM, Lee SH, et al. (1997). "Purification and binding properties of a human ficolin-like protein". J. Immunol. Methods. 204 (1): 43–9. doi:10.1016/S0022-1759(97)00029-X. PMID9202708.
Kilpatrick DC, Fujita T, Matsushita M (1999). "P35, an opsonic lectin of the ficolin family, in human blood from neonates, normal adults, and recurrent miscarriage patients". Immunol. Lett. 67 (2): 109–12. doi:10.1016/S0165-2478(98)00147-3. PMID10232391.
Taira S, Kodama N, Matsushita M, Fujita T (2001). "Opsonic function and concentration of human serum ficolin/P35". Fukushima journal of medical science. 46 (1–2): 13–23. doi:10.5387/fms.46.13. PMID11446374.
Cseh S, Vera L, Matsushita M, et al. (2003). "Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2". J. Immunol. 169 (10): 5735–43. doi:10.4049/jimmunol.169.10.5735. PMID12421953.
Ohashi T, Erickson HP (2004). "The disulfide bonding pattern in ficolin multimers". J. Biol. Chem. 279 (8): 6534–9. doi:10.1074/jbc.M310555200. PMID14660572.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Lynch NJ, Roscher S, Hartung T, et al. (2004). "L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement". J. Immunol. 172 (2): 1198–202. doi:10.4049/jimmunol.172.2.1198. PMID14707097.
Krarup A, Thiel S, Hansen A, et al. (2005). "L-ficolin is a pattern recognition molecule specific for acetyl groups". J. Biol. Chem. 279 (46): 47513–9. doi:10.1074/jbc.M407161200. PMID15331601.
Herpers BL, Immink MM, de Jong BA, et al. (2006). "Coding and non-coding polymorphisms in the lectin pathway activator L-ficolin gene in 188 Dutch blood bank donors". Mol. Immunol. 43 (7): 851–5. doi:10.1016/j.molimm.2005.06.035. PMID16076493.
Chapman SJ, Vannberg FO, Khor CC, et al. (2007). "Functional polymorphisms in the FCN2 gene are not associated with invasive pneumococcal disease". Mol. Immunol. 44 (12): 3267–70. doi:10.1016/j.molimm.2006.04.013. PMID17382393.
Munthe-Fog L, Hummelshøj T, Hansen BE, et al. (2007). "The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels". Scand. J. Immunol. 65 (4): 383–92. doi:10.1111/j.1365-3083.2007.01915.x. PMID17386030.